title: [New clinical perspectives in the management of oral direct anticoagulant agents].
authors.affiliation: Servicio de Hematología y Hemoterapia, Universidad Miguel Hernández, Hospital General Universitario, Alicante, España. Electronic address: marco_pas@gva.es.
authors.forename: Pascual
authors.initials: P
authors.lastname: Marco
authors.affiliation: Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, España.
authors.forename: José L
authors.initials: JL
authors.lastname: Zamorano
authors.affiliation: Servicio de Cirugía Ortopédica y Traumatología, Hospital General Universitario Gregorio Marañón, Madrid, España.
authors.forename: Francisco
authors.initials: F
authors.lastname: Chana
authors.affiliation: Servicio de Anestesiología-Reanimación, Hospital Clínic Universitari, Universidad Católica San Vicente Mártir, Valencia, España.
authors.forename: Juan V
authors.initials: JV
authors.lastname: Llau
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000069604:Dabigatran; D017558:Elective Surgical Procedures; D004630:Emergencies; D065427:Factor Xa Inhibitors; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019637:Orthopedic Procedures; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology; D011292:Premedication; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D065427:Factor Xa Inhibitors; D009025:Morpholines; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013876:Thiophenes; D014812:Vitamin K; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran